Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO's Clinician Well-Being Taskforce.


Journal

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
ISSN: 1548-8756
Titre abrégé: Am Soc Clin Oncol Educ Book
Pays: United States
ID NLM: 101233985

Informations de publication

Date de publication:
Jun 2021
Historique:
entrez: 1 6 2021
pubmed: 2 6 2021
medline: 16 6 2021
Statut: ppublish

Résumé

Optimizing the well-being of the oncology clinician has never been more important. Well-being is a critical priority for the cancer organization because burnout adversely impacts the quality of care, patient satisfaction, the workforce, and overall practice success. To date, 45% of U.S. ASCO member medical oncologists report experiencing burnout symptoms of emotional exhaustion and depersonalization. As the COVID-19 pandemic remains widespread with periods of outbreaks, recovery, and response with substantial personal and professional consequences for the clinician, it is imperative that the oncologist, team, and organization gain direct access to resources addressing burnout. In response, the Clinician Well-Being Task Force was created to improve the quality, safety, and value of cancer care by enhancing oncology clinician well-being and practice sustainability. Well-being is an integrative concept that characterizes quality of life and encompasses an individual's work- and personal health-related environmental, organizational, and psychosocial factors. These resources can be useful for the cancer organization to develop a well-being blueprint: a detailed start plan with recognized strategies and interventions targeting all oncology stakeholders to support a culture of community in oncology.

Identifiants

pubmed: 34061565
doi: 10.1200/EDBK_320873
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e339-e353

Auteurs

Fay J Hlubocky (FJ)

Department of Medicine, Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL.

Tait D Shanafelt (TD)

Stanford School of Medicine, Palo Alto, CA.

Anthony L Back (AL)

Seattle Cancer Care, University of Washington, Seattle, WA.

Judith A Paice (JA)

Feinberg School of Medicine, Northwestern University, Chicago, IL.

Eric D Tetzlaff (ED)

Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA.

Christopher R Friese (CR)

University of Michigan, Rogel Cancer Center, Ann Arbor MI.

Arif H Kamal (AH)

Duke Cancer Center, Durham, NC.

Daniel C McFarland (DC)

Northwell Cancer Institute, Lenox Hill Hospital, New York, NY.

Laurie Lyckholm (L)

Division of Hematology Oncology, University of Iowa, Iowa City, IA.

Colleen M Gallagher (CM)

MD Anderson Cancer Center, Houston, TX.

Monica Chatwal (M)

Moffitt Cancer Center, Tampa, FL.

Joel Saltzman (J)

Lake Health, University Hospitals, Seidman Cancer Center, Mentor, OH.

Denise Dudzinski (D)

University of Washington, Seattle, WA.

John M Burke (JM)

Rocky Mountain Cancer Center, Aurora, CO.

Ted A James (TA)

Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA.

Ray D Page (RD)

The Center for Cancer and Blood Disorders, Fort Worth, TX.

Deborah A Boyle (DA)

Advanced Oncology Nursing Resources, Phoenix, AZ.

Maria M Gonzalez (MM)

Stanford Health Care, Palo Alto, CA.

Piyush Srivastava (P)

Kaiser Permanente, Northern California (NCAL), Oakland, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH